Hinge Health hosts its first Investor Day and raises guidance
Hinge Health raised its full-year 2026 revenue guidance to a range of $818 million to $824 million, representing a $20 million increase at the midpoint from its prior outlook. The company expects 40% year-over-year revenue growth at the midpoint and a non-GAAP operating margin of 27% for the full year. Q2 2026 guidance was also raised, with revenue expected between $200 million and $202 million, reflecting 45% year-over-year growth at the midpoint.
Key figures
- Guidance
- FY26 revenue $818M-$824M (midpoint up $20M from prior); Q2 2026 revenue $200M-$202M
- Fy26 revenue growth yoy
- 40%
- Q2 2026 revenue growth yoy
- 45%
- Fy26 non gaap operating margin
- 27%
- Q2 2026 non gaap operating margin
- 25%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.